Cargando…
Improving lung cancer survival; time to move on
BACKGROUND: During the past decades, numerous efforts have been made to decrease the death rate among lung cancer patients. Nonetheless, the improvement in long-term survival has been limited and lung cancer is still a devastating disease. DISCUSSION: With this article we would like to point out tha...
Autores principales: | Heuvers, Marlies E, Hegmans, Joost P, Stricker, Bruno H, Aerts, Joachim G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528634/ https://www.ncbi.nlm.nih.gov/pubmed/23234250 http://dx.doi.org/10.1186/1471-2466-12-77 |
Ejemplares similares
-
Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment
por: Heuvers, Marlies E, et al.
Publicado: (2012) -
Antimicrobial resistance – moving forward?
por: Lomazzi, Marta, et al.
Publicado: (2019) -
Immunological profiling as a means to invigorate personalized cancer therapy
por: Hegmans, Joost PJJ, et al.
Publicado: (2013) -
Curbing the lifestyle disease pandemic: making progress on an interdisciplinary research agenda for law and policy interventions
por: Toebes, Brigit, et al.
Publicado: (2017) -
‘Treatment resistance’ in electroconvulsive therapy (ECT) patients: time to move on
por: Kellner, C. H., et al.
Publicado: (2019)